Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and with reference to its letter dated 7th November, 2022 intimating about the earning conference call for Q2 & H1 FY23 with Analysts/Investors held on 16th November, 2022, Themis Medicare has informed that it attached the transcript of the aforesaid conference call. The above information is also available on the website of the Company at https://www.themismedicare.com.
The above information is a part of company’s filings submitted to BSE.
